Clinical Trials Browser

Phase 3 × OTHER × Octreotide × Clear all

Pancreatic Neoplasms

NCT00182754 2017-04-11

Octreotide in Treating Patients With Cancer-Related Malignant Ascites

Phase 3 Completed

33 enrolled 9 charts

Tumor-Agnostic

Neoplasm Metastasis

NCT00033605 2016-07-13

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

Phase 3 Completed

130 enrolled

GastrointestinalGenitourinaryGynecologicSarcoma

Uterine Cervical Neoplasms, Diarrhea, Fallopian Tube Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT00386984 2006-10-12

Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma

Phase 3 Completed

108 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

Clinical Trials

PANasta

Octreotide in Treating Patients With Cancer-Related Malignant Ascites

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma